CSPC PHARMA (01093.HK): Grants 78.085m award shares to 205 people
On 16 October 2026, CSPC PHARMA (01093.HK) granted 78,085,000 award shares to 205 staff under its 2026 award scheme at HK$2.95 each, 0.678% of issued shares.
Key Highlights:
- The shares vest in two tranches: three-sevenths on 15 February 2027 and four-sevenths on 15 February 2028.
- After the grant, 267,588,551 shares remain available for future grants under the scheme.
NewTimeSpace News: On 16 October 2026, CSPC Pharmaceutical Group Limited (01093.HK) granted 78,085,000 restricted shares to 205 selected participants under its 2026 Share Award Scheme, about 0.678% of issued shares, subject to acceptance and vesting conditions. The purchase price is HK$2.95 per share against a closing price of HK$8.88 on the grant date.
The shares vest in two tranches, three-sevenths on 15 February 2027 and four-sevenths on 15 February 2028, subject to annual performance targets. As at the announcement date, the Trustee had bought 46,178,000 award shares on-market; after the grant, 267,588,551 shares remain available for future grants.
Tags：
- CSPC PHARMA (01093.HK): SYS6062 ADC gets China clinical trial nod
- CSPC PHARMA (01093.HK): SYS6088 trispecific antibody gets CT nod
- CSPC PHARMA (01093.HK): Phase I Data for SYS6002 in Advanced Cervical Cancer; Confirmed ORR Up to 35.9%
- CSPC PHARMA (01093.HK): 8 trials to feature at ESMO 2026, two as LBAs
- CSPC PHARMA (01093.HK): Efmedaglutide Alfa Phase III Data at EASD 2026
